Spangler Patrick D
Insider CIK 1296525 · EPOC Chief Financial Officer · OPRX Director · ULGX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OPRX OptimizeRx Corp | A Award | 2026-06-09 | 2026-06-10 | 34,517 | — | $0 | 78,732 | SEC↗ |
| OPRX OptimizeRx Corp | S Sale | 2025-08-28 | 2025-09-11 | 11,120 | $17.49 | $194.5K | 44,215 | SEC↗ |
| OPRX OptimizeRx Corp | A Award | 2025-06-11 | 2025-06-12 | 9,868 | — | $0 | 55,335 | SEC↗ |
| OPRX OptimizeRx Corp | A Award | 2024-06-07 | 2024-06-11 | 13,286 | — | $0 | 45,467 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise deriv | 2024-06-05 | 2024-06-11 | 10,061 | — | $0 | 0 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2024-06-05 | 2024-06-11 | 10,061 | — | $0 | 32,181 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise deriv | 2023-06-07 | 2023-08-18 | 4,637 | — | $0 | 0 | SEC↗ |
| OPRX OptimizeRx Corp | A Award deriv | 2023-06-07 | 2023-08-18 | 10,061 | — | $0 | 10,061 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2023-06-07 | 2023-08-18 | 4,637 | — | $0 | 22,120 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise deriv | 2023-03-31 | 2023-04-03 | 657 | — | $0 | 657 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2023-03-31 | 2023-04-03 | 657 | — | $0 | 17,483 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise deriv | 2022-12-30 | 2023-01-04 | 409 | — | $0 | 0 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2022-12-30 | 2023-01-04 | 409 | — | $0 | 16,826 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise deriv | 2022-09-29 | 2022-09-30 | 334 | — | $0 | 0 | SEC↗ |
| OPRX OptimizeRx Corp | M Exercise | 2022-09-29 | 2022-09-30 | 334 | — | $0 | 16,417 | SEC↗ |
| OPRX OptimizeRx Corp | A Award deriv | 2022-06-09 | 2022-06-13 | 4,637 | — | $0 | 4,637 | SEC↗ |
| OPRX OptimizeRx Corp | A Award deriv | 2022-03-30 | 2022-04-01 | 657 | — | $0 | 657 | SEC↗ |
| OPRX OptimizeRx Corp | A Award deriv | 2021-12-30 | 2022-01-03 | 409 | — | $0 | 743 | SEC↗ |
| OPRX OptimizeRx Corp | S Sale | 2021-11-11 | 2021-11-15 | 6,252 | $84.38 | $527.5K | 16,083 | SEC↗ |
| OPRX OptimizeRx Corp | A Award deriv | 2021-09-29 | 2021-10-01 | 334 | — | $0 | 334 | SEC↗ |
| OPRX OptimizeRx Corp | A Award | 2021-06-30 | 2021-06-30 | 407 | — | $0 | 22,335 | SEC↗ |
| OPRX OptimizeRx Corp | A Award | 2021-03-31 | 2021-04-02 | 539 | — | $0 | 21,928 | SEC↗ |
| OPRX OptimizeRx Corp | A Award | 2020-12-31 | 2021-01-05 | 802 | — | $0 | 21,389 | SEC↗ |
| OPRX OptimizeRx Corp | A Award | 2020-09-30 | 2021-01-05 | 1,183 | — | $0 | 20,587 | SEC↗ |
| OPRX OptimizeRx Corp | A Award | 2020-06-30 | 2020-07-02 | 1,937 | — | $0 | 19,404 | SEC↗ |
| OPRX OptimizeRx Corp | A Award | 2020-03-30 | 2020-03-31 | 2,784 | — | $0 | 17,467 | SEC↗ |
| OPRX OptimizeRx Corp | A Award | 2020-01-03 | 2020-01-07 | 2,084 | — | $0 | 14,683 | SEC↗ |
| OPRX OptimizeRx Corp | A Award | 2019-09-30 | 2019-10-02 | 2,084 | — | $0 | 12,599 | SEC↗ |
| OPRX OptimizeRx Corp | A Award | 2019-03-29 | 2019-03-29 | 2,084 | — | $0 | 6,347 | SEC↗ |
| OPRX OptimizeRx Corp | P Buy | 2018-10-08 | 2018-10-10 | 2,084 | — | $0 | 4,263 | SEC↗ |
| OPRX OptimizeRx Corp | P Buy | 2018-06-29 | 2018-07-03 | 2,084 | — | $0 | 2,179 | SEC↗ |
| OPRX OptimizeRx Corp | P Buy | 2018-06-27 | 2018-06-28 | 95 | $9.95 | $945 | 95 | SEC↗ |
| ULGX UROLOGIX INC | A Award | 2014-11-06 | 2014-11-21 | 45,455 | — | $0 | 155,257 | SEC↗ |
| ULGX UROLOGIX INC | A Award | 2013-11-07 | 2014-01-22 | 50,000 | — | $0 | 109,802 | SEC↗ |
| ULGX UROLOGIX INC | A Award deriv | 2012-11-16 | 2012-11-19 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ULGX UROLOGIX INC | A Award | 2012-11-16 | 2012-11-19 | 26,516 | — | $0 | 59,802 | SEC↗ |
| EPOC EPOCRATES INC | A Award deriv | 2012-01-20 | 2012-01-24 | 60,000 | — | $0 | 60,000 | SEC↗ |